Luis Ganoza
Analyst · UBS. Please state your question
Thank you. I will start by making a brief reference to our disclosure on internal controls in the press release of results and MD&A. This has been the first year of the company filing under Sarbanes-Oxley. And as of year-end, we have disclosed certain material weaknesses preventing us from concluding on the effectiveness of our internal controls over financial reporting. Under the internal controls frameworks, this in turn implies that if a material error or fraud were to occur, there is more than a reasonable chance it would not be detected. There are a few points we believe are relevant to make around the disclosure before we move on. First of all, as I just mentioned, this has been our first year under Sarbanes-Oxley. And this certainly imposes a much higher bar in terms of formalization of all aspects of the process behind financial reporting. Second is that the weaknesses disclosed have to do for the larger part with insufficient level of documentation and supporting evidence around several of our internal controls, including review controls throughout the accounting process. There have been no incidents of fraud of wrong revenue recognition as part of the issues disclosed. Up to now, we have operated under a tight and streamlined structure, favoring cost reduction in several areas of the organization, and accounting has been one of them. So this is an issue mostly related to expanding our staffing capacities, documenting of our controls and training to meet the demands of reporting under a SOX environment. For the disclosure to be complete, I do have to mention there is a related error, which has been disclosed in the year-end MD&A, and it pertains to the wrong classification in Q3 of 2016 of warrants issued upon the Goldrock acquisition as a liability as opposed to equity. This is a complex accounting matter, which was appropriately identified and reviewed with our accounting advisers as of Q3. Nonetheless, a conclusion on the appropriate accounting treatment was wrong. A final point to make on this is that the company is committed to removing these material weaknesses, and is well advanced in the execution of the necessary remediation actions. So on to Slide 11. For 2016, we recorded net sales of $210 million, up 36% from the prior year, driven by higher metal sales and prices. We reported net income of $17.9 million, compared to a loss in 2015 as Jorge mentioned, related to a $25 million impairment charge before taxes at Caylloma. Adjusted net income was $18 million compared to $6.7 million in 2015, reflecting our strong production growth, a more favorable price environment, and good cost performance throughout the year. Higher cash provided by operating activities is a reflection as well of a strong year-end revenues, margins and liquidity. Cash equivalents and short-term investments as at the end of 2016 added up to $123.6 million. On to Slide 12, for the fourth quarter, our results over the comparative period reflect the full impact of the expansion at San Jose, with revenue increase of 56% and higher cash provided by operating activities before changes in working capital of 136%. Earnings per share in the quarter was $0.04, impacted by higher income tax provision of around $0.02. On Slide 13, when breaking down our sales performance, in the left-hand side of the slide we can see the results for the fourth quarter, with higher total sales of $29.9 million and fairly even contribution from a higher metal volumes and prices of $10.4 million and $11.3 million respectively. Worth noting is our participation of zinc and lead to the overall price contribution in the amount of $5.1 million, driven by higher lead and zinc prices year-over-year of 27% and 57%. On the right-hand side of the slide, we can see the results for the year, with higher total sales of $55.5 million. The strongest contribution coming from higher volumes sold of $27.1 million, driven by increases across all of our metal products. Worth mentioning as well is the positive impact of treatment and refining charges year-over-year, with treatment charges for our concentrate products having improved between 37% and 15%. This is a continuous trend we see into 2017. In Slide 14, we see the performance of operating income and adjusted EBITDA for the full year. For adjusted EBITDA, we see a strong increase year-over-year of 67%, driven by higher EBITDA margins over sales at both San Jose and Caylloma. In the case of Caylloma in particular, we saw improved production cash cost of 16%, which contributed to a 152% increase in EBITDA. San Jose's increase in EBITDA of 62% was driven by higher sales and operating leverage as a result of the expansion. In Slide 15, for the quarter, we have a similar pattern, with even higher increase in EBITDA and positive impact on margins over the comparative period as a result of higher impact of prices in the quarter-over-quarter comparison, and the full quarter of expanded production at San Jose in Q4 of 2016. In Slide 16, expenses, we have a relatively stable corporate G&A for the full year of $9.5 million, although higher expense in the quarter of $2.6 million, up 30% over Q4 of 2015. Moving forward, we should expect corporate G&A expenses per quarter to stay around these levels as a result of the growth of the company and added demands on meeting, amongst other things, internal controls requirements and results regulation. Our share-based compensation for the full year was significantly above the comparative period, with $14.1 million in 2016, compared to $1.5 million in 2015. This last figure is not actually shown in the slide. Out of this total amount, around $7.5 million is related to the mark-to-market effect from the increase in our share price throughout the year. This impact is in turn related to cash-settled instruments, being used on share-based payment as opposed to share-settled instruments, which are not mark-to-market. Our effective tax rate for the year was 67%, as it was impacted by three main items, the most important being the share-based compensation expense, which is nondeductible. The mark-to-market impact on share-based payments reflects, to a large extent, an increase in obligations that will be paid in future periods. The impact of the single effect is of 9 percentage points on the effective tax rate. Additionally, impacting our effective tax rate was a one-time withholding tax of $2.7 million recorded in Q4 and the devaluation of the Mexican peso throughout the year, which increases our deferred tax expense. Outside of these factors, our effective tax rate would be around 47%, more in line with what we expect to see on a more normalized basis. For the quarter, we have a similar effect, with the most impact coming from the withholding tax and the foreign exchange impact. In Slide 17, we show a cash bridge for both the full year and the fourth quarter at the bottom. The opening and closing balance shown at both ends of the bridge is comprised of cash and short-term investments. As seen in the graph for Q4, we had cash accumulation in the last quarter of the year of $20.4 million. A caveat here is we paid income tax of $5.4 million, but accrued $11.3 million, including the one-time withholding of $2.7 million. Adjusting for this, plus financing items, free cash flow was more in the range of $10 million to $13 million for the quarter. To you, Carlos.